Skip Navigation Links
 



                     


 



   
    Learn More     Subscribe    
Join Now!      Login
 
 
 
FREE HEALTH
NEWSLETTER
 
 
Vitamin D Poll
Are you currently taking a Vitamin D supplement?
 
 
 
 
N
atural Medicine Research
 


Melatonin Could Help Patients on Chemotherapy

© Ray Sahelian MD

The following is one in an ongoing series of columns entitled Natural Medicine Research by Ray Sahelian MD. View all columns in series
Ray Sahelian One of the serious drawbacks of chemotherapy is the resultant destruction of many aspects of the immune system along with destruction of various blood cells. In experiments on rodents, it has been shown that melatonin could counteract chemotherapy-induced immune suppression. To test whether this same positive response could be replicated in humans, Dr. Lissoni and colleagues, from the Division of Radiation Oncology, S. Gerardo Hospital, in Milan, Italy, evaluated the role of melatonin given with the chemotherapy. Eighty patients were randomized to receive either the chemotherapy alone, or the chemotherapy with melatonin. Thirty-five of these patients had lung cancer, 31 had breast cancer, and 14 had various gastrointestinal tract tumors. Lung cancer patients were receiving cisplatin, the breast cancer patients were being treated with mitoxantrone, and the patients with gastrointestinal tumors were receiving 5-fluorouracil. The melatonin was given in the evening at a dose of 20 mg.

At the end of the study, patients given the melatonin had a higher number of platelets, had less weakness, and less nerve damage. Loss of hair and nausea were not influenced by the melatonin. The authors say, "This pilot study seems to suggest that the concomitant administration of the pineal hormone melatonin during chemotherapy may prevent some chemotherapy-induced side-effects, particularly myelosuppression and neuropathy."

Comments: Over the past few years a number of studies have shown that melatonin plays a positive role in the therapy of cancer patients. At this point, we don't know the ideal dose of melatonin to use with various types of cancers, nor do we know the ideal time to administer this hormone. However, there is enough evidence at this time to serious consider the nightly use of a small amount of melatonin, perhaps in the 0.5 to 3 mg range, in anyone who has cancer. However, this should be done under the guidance of health care practitioner.

Lissoni P, Tancini G, Barni S, Paolorossi F, Ardizzoia A, Conti A, Maestroni G. Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin. Support Care Cancer, March, 5:126-9, 1997.

Add your comment      
About The Author
Ray Sahelian, M.D., is a popular and respected physician who has been seen on numerous television programs including NBC Today, Dateline NBC, and CNN, and quoted by countless major magazines such as Newsweek He is the bestselling author of ...more
 
Share   Facebook   Buzz   Delicious   Digg   Twitter  
 
 
 
 
 
 
From Our Sponsor
 
 
 
 
 
 
Featured Events
Wellness Inventory Certification Training - Level I
     February 18-May 20, 2014
     Los Angeles, CA USA
 
Additional Calendar Links
 
Wellness, Finding Meaning, dimension!

Search   
Home       Wellness       Health A-Z       Alternative Therapies       Find a Practitioner       Healthy Products       Bookstore       Wellness Inventory
Healthy Kitchen       Healthy Woman       Healthy Man       Healthy Child       Healthy Aging       Wellness Center       Nutrition Center       Fitness Center
Free Newsletter      What Doctor's Don't Tell You      Stevia.com      Discount Lab Tests      First Aid      Global Health Calendar      Privacy Policy     Contact Us

Disclaimer: The information provided on HealthWorld Online is for educational purposes only and IS NOT intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek professional medical advice from your physician or other qualified healthcare provider with any questions you may have regarding a medical condition.